Menu ×

HEALTHCARE & PHARMACEUTICAL

Myositis Treatment Market Segmentation by Type (Dermatomyositis, Inclusion-Body Myositis, Juvenile Myositis, Polymyositis, and Toxic Myositis); by Treatment (Corticosteroids, Immunosuppressant Drug, Physical Therapy, and Others); and by End-User (Hospital, Homecare, Specialty Clinics, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Myositis Treatment Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • June, 2021: Novartis AG, the leading pharmaceutical company for global drug distribution, announced to collaborate with Hewlett Packard Enterprise to expand its portfolio in medical devices production.

  • September, 2020: Kezar Life Sciences is conducting phase-2 study and trial of KZR-616, to evaluate the safety and efficacy in patients with polymyositis and dermatomyositis, at the Myositis Association international annual patient conference.

  • May, 2018: The Myositis Association (TMA) announced May as Myositis Awareness Month, to spread awareness regarding the autosomal muscular disease. 

Global Myositis Treatment Market Highlights over 2022 – 2030

The global myositis treatment market is estimated to grow at a notable CAGR over the forecast period, i.e., 2022 – 2030. Myositis is a chronic condition of muscles, causing progressive inflammation in certain muscles, which can even lead to morbidity, complete loss of movement, and even death. The growth of the market can be attributed to the poor muscle health, prevalent globally due to lack of proper physical activities. Moreover, myositis is more common amongst the older population, or people with underlying musculoskeletal disorders. In turn, the growing prevalence of muscle-related diseases is estimated to boost the market growth. According to the data by the World Health Organization (WHO), 1.71 billion people globally suffer with some kind of musculoskeletal conditions. Moreover, the rising geriatric population across the globe is further projected to boost the market growth. According to the World Bank, 9.318% of the total global population aged above 65 years, in 2020.

Myositis Treatment Market Graph

Get more information on this reportDownload Sample PDF

Furthermore, there is no cure for myositis, and treatments are basically aimed towards relieving the symptoms. The symptoms include skin rashes, difficulty in walking or rising from seated position, tripping and loss of balance, weakened hand grip, difficulty swallowing, and muscle weakness and pain. As a result, there is a surge in demand for developing an effective treatment method for curing myositis. In addition to this, the growing investment in the R&D activities is estimated to boost the market growth.  According to the World Bank data, 2.204% of the global GDP was spent for R&D activities in 2018. 

Expenditure

The market is segmented by type into dermatomyositis, inclusion-body myositis, juvenile myositis, polymyositis, and toxic myositis, out of which, the inclusion-body myositis segment is anticipated to hold the notable share in the global myositis treatment market over the forecast period on account of high prevalence of this type of myositis amongst the older population. According to the data by the National Organization of Rare Diseases (NORD), 51-139 out of every 1 million individuals over 50 years of age suffer from inclusion-body myositis globally.

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure Per Capita Graph According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Myositis Treatment Market Regional Synopsis

On the basis of geographical analysis, the global myositis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of high prevalence of musculoskeletal diseases in the region, backed by high geriatric population. According to a report by the WHO, more than 369 million people suffer from muscle-related diseases in the South-East Asia region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the high health awareness amongst the population, along with easy access of quality healthcare in the developed nations.

Myositis Treatment Market Share Image

Get more information on this reportDownload Sample PDF

The global myositis treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global myositis treatment market includes the following segments:

By Type

  • Dermatomyositis
  • Inclusion-Body Myositis
  • Juvenile Myositis
  • Polymyositis
  • Toxic Myositis

By Treatment

  • Corticosteroids
  • Immunosuppressant Drug
  • Physical Therapy
  • Others

By End-User

  • Hospital
  • Homecare
  • Specialty Clinics
  • Others

Growth Drivers

  • Rising Prevalence of Myositis and Other Musculoskeletal Disorders
  • Increasing Global Geriatric Population

Challenges

  • Difficult Diagnosis of Myositis
  • Lack of Health Awareness amongst People in Undeveloped Regions

Top Featured Companies Dominating the Market

  • Baxter International, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Eli Lilly and Company
  • Novartis AG
  • Sanofi-aventis Groupe
  • Abbott Laboratories
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Siemens Healthcare GmbH
  • Pfizer Inc.
  • Becton, Dickinson and Company

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved